TEMODAR

Manufacturer:

Merck

Name:

TEMODAR

HCPCS Code Descriptor:

Temozolomide, oral, 5 mg

Category:

J Code

HCPCS:

J8700

NDC(s):

67877-0542-07, 67877-0541-14, 67877-0541-07, 67877-0540-07, 67877-0540-14, 67877-0539-07, 67877-0539-14, 67877-0538-14, 67877-0537-07, 67877-0537-14, 67877-0538-07, 65162-0806-51, 65162-0805-51, 65162-0805-14, 65162-0804-51, 65162-0804-14, 65162-0803-51, 65162-0803-14, 65162-0802-51, 65162-0802-14, 65162-0801-14, 65162-0801-51, 64980-0338-05, 64980-0334-05, 64980-0335-14, 50268-0761-12, 50268-0762-12, 47335-0930-21, 47335-0930-72, 47335-0930-74, 47335-0930-80, 47335-0929-72, 47335-0929-74, 47335-0929-80, 47335-0893-74, 47335-0893-80, 47335-0929-21, 47335-0891-80, 47335-0892-21, 47335-0892-72, 47335-0892-74, 47335-0892-80, 47335-0891-72, 47335-0891-74, 47335-0890-80, 47335-0891-21, 47335-0890-74, 47335-0890-21, 47335-0890-72, 43975-0257-05, 43975-0256-14, 43975-0252-14, 43975-0253-05, 43975-0253-14, 43975-0254-05, 43975-0254-14, 43975-0255-05, 43975-0255-14, 43975-0256-05, 43975-0252-05, 16729-0130-53, 16729-0130-54, 16729-0129-53, 16729-0129-54, 16729-0050-54, 16729-0051-53, 16729-0049-53, 16729-0049-54, 16729-0050-53, 16729-0048-53, 16729-0048-54, 00781-2696-75, 00781-2695-44, 00781-2695-75, 00781-2694-75, 00781-2694-44, 00781-2692-44, 00781-2692-75, 00781-2693-44, 00781-2693-75, 00781-2691-44, 00781-2691-75

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Oral

About:

TEMODAR is an Oncology drug manufactured by Merck and administered via the Oral route of administration. The J Code: J8700 is aligned to the drug TEMODAR.